Mr Sudarshan Ananth, territory VP & business head, HVAC & transport, India Climate Business Unit, Ingersoll Rand
Ingersoll Rand brings expertise to pharma and healthcare industry with sustainable solutions in the areas of HVAC and compressed air systems, tools, security technologies, and mobile or static refrigeration.
The HVAC for pharma market is growing at a CAGR of 8 percent, while the pharma HVAC market was around $10 million for chillers and AHU (air handling unit) in 2014.
"The government has already unveiled ‘Pharma Vision 2020' aimed at making India a global leader in end-to-end drug manufacturing, thereby making this sector highly lucrative for investments and growth," said Mr Sudarshan Ananth, territory VP & business head, HVAC & transport, India Climate Business Unit, Ingersoll Rand.
India being the 3rd largest producer of pharma products and responsible for 8 percent of the world's production is a strategic market for HVAC products.